ARTELO BIOSCIENCES, INC. Other Noncash Expense
ARTELO BIOSCIENCES, INC. (ARTL) reported Other Noncash Expense of $18.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashExpense · last filed 2026-08-12
- ARTELO BIOSCIENCES, INC. other noncash expense for the quarter ending 2026-06-30 was $9.00K, a 0.00% change year-over-year.
- ARTELO BIOSCIENCES, INC. other noncash expense for the quarter ending 2026-03-31 was $9.00K, a 12.50% increase year-over-year.
- ARTELO BIOSCIENCES, INC. other noncash expense for the quarter ending 2025-12-31 was $9.00K, a 0.00% change year-over-year.
- ARTELO BIOSCIENCES, INC. other noncash expense for the quarter ending 2025-09-30 was $9.00K, a 12.50% increase year-over-year.
- ARTELO BIOSCIENCES, INC. other noncash expense for fiscal 2022 was $39.00K.
- ARTELO BIOSCIENCES, INC. other noncash expense for fiscal 2021 was $7.00K.
- ARTELO BIOSCIENCES, INC. other noncash expense for fiscal 2020 was $0.00.
| Period end | Other Noncash Expense 3 month | Other Noncash Expense 4 month | Other Noncash Expense 6 month | Other Noncash Expense 9 month | Other Noncash Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $18.00K 10-Q · filed 2026-08-12 | $27.00K derived: sum of 3 quarters · filed 2026-08-12 | $36.00K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2026-03-31 | $9.00K 10-Q · filed 2026-05-14 | $18.00K derived: sum of 2 quarters · filed 2026-05-14 | $27.00K derived: sum of 3 quarters · filed 2026-05-14 | $36.00K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-12-31 | $9.00K derived: 8-K 12 month − 10-Q 9 month · filed 2026-03-17 | $18.00K derived: sum of 2 quarters · filed 2026-03-17 | $27.00K derived: sum of 3 quarters · filed 2026-08-12 | $35.00K 8-K · filed 2026-03-17 | |
| 2025-09-30 | $9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $18.00K derived: sum of 2 quarters · filed 2026-08-12 | $26.00K 10-Q · filed 2025-11-12 | $35.00K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-06-30 | $9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $17.00K 10-Q · filed 2026-08-12 | $26.00K derived: sum of 3 quarters · filed 2026-08-12 | $34.00K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-03-31 | $8.00K 10-Q · filed 2026-05-14 | $17.00K derived: sum of 2 quarters · filed 2026-05-14 | $25.00K derived: sum of 3 quarters · filed 2026-05-14 | $33.00K derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | $9.00K derived: 8-K 12 month − 10-Q 9 month · filed 2026-03-17 | $17.00K derived: sum of 2 quarters · filed 2026-03-17 | $25.00K derived: sum of 3 quarters · filed 2026-03-17 | $33.00K 8-K · filed 2026-03-17 | |
| 2024-09-30 | $8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $16.00K derived: sum of 2 quarters · filed 2025-11-12 | $24.00K 10-Q · filed 2025-11-12 | $34.00K derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | $8.00K derived: 10-Q 6 month − 8-K 3 month · filed 2025-08-13 | $16.00K 10-Q · filed 2025-08-13 | $26.00K derived: sum of 3 quarters · filed 2025-08-13 | $35.00K derived: sum of 4 quarters · filed 2025-08-13 | |
| 2024-03-31 | $8.00K 8-K · filed 2025-07-11 | $18.00K derived: sum of 2 quarters · filed 2025-07-11 | $27.00K derived: sum of 3 quarters · filed 2025-07-11 | $37.00K derived: sum of 4 quarters · filed 2025-07-11 | |
| 2023-12-31 | $10.00K derived: 8-K 12 month − 10-Q 9 month · filed 2025-07-11 | $19.00K derived: sum of 2 quarters · filed 2025-07-11 | $29.00K derived: sum of 3 quarters · filed 2025-07-11 | $40.00K 8-K · filed 2025-07-11 | |
| 2023-09-30 | $9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $19.00K derived: sum of 2 quarters · filed 2024-11-12 | $30.00K 10-Q · filed 2024-11-12 | $41.00K derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | $10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $21.00K 10-Q · filed 2024-08-13 | $32.00K derived: sum of 3 quarters · filed 2024-08-13 | $41.00K derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | $11.00K 10-Q · filed 2024-05-13 | $22.00K derived: sum of 2 quarters · filed 2024-05-13 | $31.00K derived: sum of 3 quarters · filed 2024-05-13 | $43.00K derived: sum of 4 quarters · filed 2024-05-13 | |
| 2022-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $20.00K derived: sum of 2 quarters · filed 2024-03-25 | $32.00K derived: sum of 3 quarters · filed 2024-03-25 | $39.00K 10-K · filed 2024-03-25 | |
| 2022-09-30 | $9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $21.00K derived: sum of 2 quarters · filed 2023-11-13 | $28.00K 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $19.00K 10-Q · filed 2023-08-10 | |||
| 2022-03-31 | $7.00K 10-Q · filed 2023-05-11 | ||||
| 2021-12-31 | $10.00K 10-K · filed 2023-03-31 | ||||
| 2021-11-30 | $7.00K 10-Q · filed 2022-01-12 | ||||
| 2021-09-30 | $8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $10.00K derived: sum of 2 quarters · filed 2022-11-08 | $10.00K 10-Q · filed 2022-11-08 | ||
| 2021-08-31 | $7.00K 10-K · filed 2023-03-31 | ||||
| 2021-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $2.00K 10-Q · filed 2022-08-09 | |||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-12 | ||||
| 2020-12-31 | $0.00 10-KT · filed 2022-03-21 | ||||
| 2020-11-30 | $0.00 10-Q · filed 2022-01-12 | ||||
| 2020-08-31 | $0.00 10-KT · filed 2022-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |